[The immunological aspects of the antibacterial therapy of peptic ulcer patients].
Essence and potency of immunological effects produced by some anti-bacterial drugs used in the treatment of peptic ulcer were determined in the course of immunological survey of patients. Trichopol and--to the less extent--furazolidone were established to provide immunocorrective effect and prevent exacerbation better than amoxicillin. The latter, to the contrary, aggravates secondary immune deficiency.
Bychkova
N G
NG
Petrov
A V
AV
Perederiĭ
V G
VG
Iurchenko
E S
ES
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000658:Amoxicillin / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005664:Furazolidone / Q000627:therapeutic use; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000276:immunology*; D016480:Helicobacter pylori; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000276:immunology*; D012008:Recurrence
D000276:Adjuvants, Immunologic; D000897:Anti-Ulcer Agents; D008795:Metronidazole; D005664:Furazolidone; D000658:Amoxicillin
Immunologicheskie aspekty antibakterial'noĭ terapii bol'nykh iazvennoĭ bolezn'iu.